images (140×140)   Dow University of Health Sciences Library Catalogue

Welcome to Dow University of Health Sciences Library Online Public Access Catalog

The art of drug synthesis / edited by Douglas S. Johnson, Jie Jack Li.

Contributor(s): Material type: TextPublication details: Hoboken, N.J. : Wiley-Interscience, c2007.Description: xv, 276 p. : illISBN:
  • 9780471752158 (cloth);0471752150 (cloth)
Subject(s): NLM classification:
  • QV 744
Contents:
The role of medicinal chemistry in drug discovery / John A. Lowe III -- Process research: how much? how soon? / Neal G. Anderson -- Aromatase inhibitors for breast cancer: exemestane (aromasin), anastrozole (arimidex), and letrozole (femara) / Jie Jack Li -- Quinolone antibiotics: levofloxacin (levaquin), moxifloxacin (avelox), gemifloxacin (factive), and garenoxacin (T-3811) / Chris Limberakis -- Triazole antifungals: itraconazole (sporanox), fluconazole (diflucan), voriconazole (vfend), and fosfluconazole (prodif) / Andrew S. Bell -- Non-nucleoside HIV reverse transcriptase inhibitors / Arthur Harms -- Neuraminidase inhibitors for influenza: oseltamivir phosphate (tamiflu), and zanamivir (relenza) / Douglas S. Johnson and Jie Jack Li -- Peroxisome proliferator-activated receptor (PPAR) agonists for type 2 diabetes / Jin Li -- Angiotensin AT1 antagonists for hypertension / Larry Yet -- Leading ACE inhibitors for hypertension / Victor J. Cee and Edward J. Olhava -- Dihydropyridine calcium channel blockers for hypertension / Daniel P. Christen -- Second-generation HMG-CoA reductase inhibitors /Jeffrey A. Pfefferkorn -- Cholesterol absorption inhibitors: ezetimibe (zetia) / Stuart B. Rosenblum -- Dual selective serotonin and norepinephrine reuptake inhibitors (SSNRIs) for depression / Marta Pin??eiro-Nun??ez -- GABAA receptor agonists for insomnia: zolpidem (ambien), zaleplon (sonata), eszopiclone (estorra, lunesta), and indiplon / Peter R. Guzzo -- [alpha]2[delta] ligands: neurontin (gabapentin) and lyrica (pregabalin) / Po-Wai Yuen -- Approved treatments for attention deficit hyperactivity disorder: amphetamine (adderall), methylphenidate (ritalin), and atomoxetine (stratterra) / David L. Gray.
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Status Barcode
Books Dow International Medical College Dow International Medical College QV 744 .A78 2007 (Browse shelf(Opens below)) Available 00002187

Includes bibliographical references and index.

The role of medicinal chemistry in drug discovery / John A. Lowe III -- Process research: how much? how soon? / Neal G. Anderson -- Aromatase inhibitors for breast cancer: exemestane (aromasin), anastrozole (arimidex), and letrozole (femara) / Jie Jack Li -- Quinolone antibiotics: levofloxacin (levaquin), moxifloxacin (avelox), gemifloxacin (factive), and garenoxacin (T-3811) / Chris Limberakis -- Triazole antifungals: itraconazole (sporanox), fluconazole (diflucan), voriconazole (vfend), and fosfluconazole (prodif) / Andrew S. Bell -- Non-nucleoside HIV reverse transcriptase inhibitors / Arthur Harms -- Neuraminidase inhibitors for influenza: oseltamivir phosphate (tamiflu), and zanamivir (relenza) / Douglas S. Johnson and Jie Jack Li -- Peroxisome proliferator-activated receptor (PPAR) agonists for type 2 diabetes / Jin Li -- Angiotensin AT1 antagonists for hypertension / Larry Yet -- Leading ACE inhibitors for hypertension / Victor J. Cee and Edward J. Olhava -- Dihydropyridine calcium channel blockers for hypertension / Daniel P. Christen -- Second-generation HMG-CoA reductase inhibitors /Jeffrey A. Pfefferkorn -- Cholesterol absorption inhibitors: ezetimibe (zetia) / Stuart B. Rosenblum -- Dual selective serotonin and norepinephrine reuptake inhibitors (SSNRIs) for depression / Marta Pin??eiro-Nun??ez -- GABAA receptor agonists for insomnia: zolpidem (ambien), zaleplon (sonata), eszopiclone (estorra, lunesta), and indiplon / Peter R. Guzzo -- [alpha]2[delta] ligands: neurontin (gabapentin) and lyrica (pregabalin) / Po-Wai Yuen -- Approved treatments for attention deficit hyperactivity disorder: amphetamine (adderall), methylphenidate (ritalin), and atomoxetine (stratterra) / David L. Gray.

There are no comments on this title.

to post a comment.



©2026, All rights reserved. Dow University of Health Sciences, Karachi, Pakistan.